| Reference |
|---|
Bang H, Lee K, Park M, Sun E, Cho S, Chung I, et al. Dynamic changes in immune cells in humanized liver metastasis and subcutaneous xenograft mouse models. Sci Rep. 2024;14:20338 pubmed publisher |
Park E, Mun H, Seo E, Hwang S, Lee J, Song S, et al. CAR NK92 Cells Targeting BCMA Can Effectively Kill Multiple Myeloma Cells Both In Vitro and In Vivo. Biomedicines. 2024;12: pubmed publisher |
Sugi T, Katoh Y, Ikeda T, Seta D, Iwata T, Nishio H, et al. SCD1 inhibition enhances the effector functions of CD8+ T cells via ACAT1-dependent reduction of esterified cholesterol. Cancer Sci. 2024;115:48-58 pubmed publisher |
Wu W, Shiu C, Tong T, LEUNG S, Hui C. Suppression of NK Cell Activation by JAK3 Inhibition: Implication in the Treatment of Autoimmune Diseases. J Immunol Res. 2023;2023:8924603 pubmed publisher |
Mondal T, Gaur H, Wamba B, Michalak A, Stout C, Watson M, et al. Characterizing the regulatory Fas (CD95) epitope critical for agonist antibody targeting and CAR-T bystander function in ovarian cancer. Cell Death Differ. 2023;30:2408-2431 pubmed publisher |
Berlin F, Mogren S, Ly C, Ramu S, Hvidtfeldt M, Uller L, et al. Mast Cell Tryptase Promotes Airway Remodeling by Inducing Anti-Apoptotic and Cell Growth Properties in Human Alveolar and Bronchial Epithelial Cells. Cells. 2023;12: pubmed publisher |
Lim Y, Lee A, Jiang X, Scott J, Cofie A, Kumar S, et al. NK cell-derived extracellular granzyme B drives epithelial ulceration during HSV-2 genital infection. Cell Rep. 2023;42:112410 pubmed publisher |
Rasoulouniriana D, Santana Magal N, Gutwillig A, Farhat Younis L, Tal L, Amar S, et al. T Cells Expressing a Modified FcγRI Exert Antibody-Dependent Cytotoxicity and Overcome the Limitations of CAR T-cell Therapy against Solid Tumors. Cancer Immunol Res. 2023;11:792-809 pubmed publisher |
Wang Y, Zhao Y, Guo W, Yadav G, Bhaskarla C, Wang Z, et al. Genome-wide gain-of-function screening characterized lncRNA regulators for tumor immune response. Sci Adv. 2022;8:eadd0005 pubmed publisher |
Heath J, Chour W, Choi J, Xie J, Chaffee M, Schmitt T, et al. Large libraries of single-chain trimer peptide-MHCs enable rapid antigen-specific CD8+ T cell discovery and analysis. Res Sq. 2022;: pubmed publisher |
An S, Yang B, Jang G, Kim D, Kim J, Oh S, et al. Combined IgE neutralization and Bifidobacterium longum supplementation reduces the allergic response in models of food allergy. Nat Commun. 2022;13:5669 pubmed publisher |
Vetrei C, Passariello M, Froechlich G, Rapuano Lembo R, Sasso E, Zambrano N, et al. Novel Combinations of Human Immunomodulatory mAbs Lacking Cardiotoxic Effects for Therapy of TNBC. Cancers (Basel). 2021;14: pubmed publisher |
Alishah K, Birtel M, Masoumi E, Jafarzadeh L, Mirzaee H, Hadjati J, et al. CRISPR/Cas9-mediated TGFβRII disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells in vitro. J Transl Med. 2021;19:482 pubmed publisher |
Serrano R, Coch C, Peters C, Hartmann G, Wesch D, Kabelitz D. Monocyte-dependent co-stimulation of cytokine induction in human γδ T cells by TLR8 RNA ligands. Sci Rep. 2021;11:15231 pubmed publisher |
Marcq E, Van Audenaerde J, De Waele J, Merlin C, Pauwels P, van Meerbeeck J, et al. The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3. Cancers (Basel). 2021;13: pubmed publisher |
Jonescheit H, Oberg H, Gonnermann D, Hermes M, Sulaj V, Peters C, et al. Influence of Indoleamine-2,3-Dioxygenase and Its Metabolite Kynurenine on γδ T Cell Cytotoxicity against Ductal Pancreatic Adenocarcinoma Cells. Cells. 2020;9: pubmed publisher |
Muñoz D, Yannone S, Daemen A, Sun Y, Vakar Lopez F, Kawahara M, et al. Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging. JCI Insight. 2019;5: pubmed publisher |
Otterdal K, Berg A, Michelsen A, Patel S, Tellevik M, Haanshuus C, et al. Soluble markers of neutrophil, T-cell and monocyte activation are associated with disease severity and parasitemia in falciparum malaria. BMC Infect Dis. 2018;18:670 pubmed publisher |
Kim M, Pyo S, Kang C, Lee C, Lee H, Choi S, et al. Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer. PLoS ONE. 2018;13:e0198347 pubmed publisher |
Yingling J, McMillen W, Yan L, Huang H, Sawyer J, Graff J, et al. Preclinical assessment of galunisertib (LY2157299 monohydrate), a first-in-class transforming growth factor-β receptor type I inhibitor. Oncotarget. 2018;9:6659-6677 pubmed publisher |
Liu Y, Wang Y, Ding G, Yang T, Yao L, Hua J, et al. JAK2 inhibitor combined with DC-activated AFP-specific T-cells enhances antitumor function in a Fas/FasL signal-independent pathway. Onco Targets Ther. 2016;9:4425-33 pubmed publisher |
